Home
|
Press
|
Events
|
Eshare
Sign in
/
Register
0
Shopping Cart
X
Close
My Products (0 items)
My shopping cart is empty.
.
Sign in
/
Register
X
Close
Login/Register
Email
Password
INDUSTRIES
Agriculture
Chemicals
Food & Feed
Pesticides
Titanium Dioxide (TiO2)
Dairy Products
Full Industry List
ONLINE DATABASE
PRODUCTS & SERVICE
Products' Introduction
Industrial Reports
Newsletters
Market Data
Content Byte
Agrochemical Regulatory
Customized solutions
IMPACT FACTOR
MARKET NEWS
Agriculture
Chemicals
Food & Feed
Other
ABOUT
About CCM
Why CCM?
CCM Story
CCM Clients
Events
Career
Company news
CONTACT
Home
Product
Newsletters
>
卫信康:2017年上半年研发项目进展顺利
Read online
卫信康:2017年上半年研发项目进展顺利
8月29日,西藏卫信康医药股份有限公司Tibet Weixinkang Medicine CO.,Ltd.(卫信康)发布2017年上半年年报,营业收入18,878.99万元(USD28.64 million),比去年同期下降11.38%;归属于上市公司股东的净利润6,476.80万元(USD9.83 million),比去年同期增长0.24%。另外,卫信康表示,2017年上半年,延续了医改不断深化的节奏,进一步细化仿制药一致性评价相关规则,加快药品审批审评速度,在此形势下,卫信康研发项目进展顺利...
Vitamins China E-News 201709(Chinese version)
Add to DIY report
Select whole article
I haven't create reports,
create a new report
right now!
Recommend Newsletters
Crop Farming in China
2016/05/31
More>>
Report on Glyphosate Business Opportunities Worldwide
2016/07/27
More>>
Specialised Control and Prevention of Pests and Diseases for Crops in China
2016/07/12
More>>
Loading...